Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Site platform updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T03:50:07.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision banner updated to v3.4.2; the previous notices about funding lapses and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:33:22.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A site-wide notice about government funding delays and current operating status is added, and the page shows a revision update to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:38:13.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now includes a Show glossary toggle and new metadata labels: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T05:52:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 instead of v3.3.3, indicating a minor update. No changes to the study details or content are evident.
    Difference
    0.1%
    Check dated 2026-01-14T02:43:03.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added New York as a location under the Locations section and updated the page to revision 3.3.3; the old 'New York Locations' listing and the 'HHS Vulnerability Disclosure' footer link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:44:35.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.